Bristol-Myers Squibb Beats Q2 Expectations, Boosts Guidance on Rising Drug Sales
Key Takeaways Bristol-Myers Squibb’s second-quarter results beat revenue and adjusted EPS expectations. The company raised …
Apple’s Fortunes in China Worsen, Research Firms Say
KEY TAKEAWAYS Apple is suffering in China as local rivals overtake it, three new reports …
Watch These Eli Lilly Stock Price Levels as Weight-Loss Drug Competition Rises
Key Takeaways Eli Lilly shares dropped more than 4% on Thursday as investors assessed the …
Dexcom Stock Plummets on Earnings Miss, Guidance Cut
Key Takeaways Shares of Dexcom tumbled in extended trading Thursday after the company reported second-quarter …
NYCB Faces a Tough Road to Profitability
Key Takeaways New York Community Bancorp on Thursday lowered its profit guidance for 2025 and …
Edwards Lifesciences Sinks on Outlook for Key Product
Key Takeaways The S&P 500 slipped 0.5% on Thursday, July 25, as tech stocks faltered …
Edwards Lifesciences Stock Plummeted Today. Here’s Why
Key Takeaways Edwards Lifesciences cut sales-growth estimates for its biggest source of revenue, a heart …
How OpenAI’s New ‘SearchGPT’ Could Compete With Google
Key Takeaways Microsoft-backed OpenAI announced a new artificial intelligence (AI) search tool called SearchGPT on …
Bitcoin Dips Below $64K, Ether Drags on ETF Outflows
Key Takeaways Ether is down more than 7% Thursday and bitcoin briefly dipped below $64,000 …
Investors Rescue Nvidia Stock From Another Rout
Key Takeaways Nvidia shares tumbled nearly 7% in early trading Thursday, extending the previous session’s …